| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Endocrinology, University of Oxford, Radcliffe Infirmary (P.J.H., J.A.H.W.), Oxford, United Kingdom OX2 7JS; and Departments of Medicine (E.M.G., C.R., V.K.K.C.), Psychiatry (F.A.H.), Community Medicine (A.T.P.), and Anatomy (J.H.), University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom CB2 2QQ
Address all correspondence and requests for reprints to: Prof. Krishna Chatterjee, Department of Medicine, Level 5, Addenbrookes Hospital, Hills Road, Cambridge, United Kingdom CB2 2QQ. E-mail: kkc1{at}mole.bio.cam.ac.uk
Dehydroepiandrosterone (DHEA) and DHEA
sulfate (DHEAS) are adrenal precursors of steroid biosynthesis and
centrally acting neurosteroids. Glucocorticoid and mineralocorticoid
deficiencies in Addisons disease require life-long hormone
replacement, but the associated failure of DHEA synthesis
is not corrected. We conducted a randomized, double blind study in
which 39 patients with Addisons disease received either 50 mg oral
DHEA daily for 12 weeks, followed by a 4-week washout
period, then 12 weeks of placebo, or vice versa. After
DHEA treatment, levels of DHEAS and
4-androstenedione rose from subnormal to within the
adult physiological range. Total testosterone increased from subnormal
to low normal with a fall in serum sex hormone-binding globulin in
females, but with no change in either parameter in males. In both
sexes, psychological assessment showed significant enhancement of
self-esteem with a tendency for improved overall well-being. Mood and
fatigue also improved significantly, with benefit being evident in the
evenings. No effects on cognitive or sexual function, body composition,
lipids, or bone mineral density were observed. Our results indicate
that DHEA replacement corrects this steroid deficiency
effectively and improves some aspects of psychological function.
Beneficial effects in males, independent of circulating testosterone
levels, suggest that it may act directly on the central nervous system
rather than by augmenting peripheral androgen biosynthesis. These
positive effects, in the absence of significant adverse events, suggest
a role for DHEA replacement therapy in the treatment of
Addisons disease.
This article has been cited by other articles:
![]() |
K. Dhatariya Dehydroepiandrosterone Sulfate Has Not Been Substantiated as an Anabolic Hormone Arch Intern Med, July 14, 2008; 168(13): 1470 - 1470. [Full Text] [PDF] |
||||
![]() |
Z Hochberg Juvenility in the context of life history theory Arch. Dis. Child., June 1, 2008; 93(6): 534 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Gurnell, P. J. Hunt, S. E. Curran, C. L. Conway, E. M. Pullenayegum, F. A. Huppert, J. E. Compston, J. Herbert, and V. K. K. Chatterjee Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 400 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.-C. Koschker, M. Quinkler, O. Decker, W. Arlt, and B. Allolio Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3912 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lovas and E. S Husebye Continuous subcutaneous hydrocortisone infusion in Addison's disease Eur. J. Endocrinol., July 1, 2007; 157(1): 109 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Panjari and S. R. Davis DHEA therapy for women: effect on sexual function and wellbeing Hum. Reprod. Update, May 1, 2007; 13(3): 239 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, and G. Johannsson Premature Mortality in Patients with Addison's Disease: A Population-Based Study J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4849 - 4853. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brooke, L. A. Kalingag, F. Miraki-Moud, C. Camacho-Hubner, K. T. Maher, D. M. Walker, J. P. Hinson, and J. P. Monson Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3773 - 3779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tellez, M. Comabella, E v. Julia, J. Rio, M a. Tintore, L. Brieva, C. Nos, and X. Montalban Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone Multiple Sclerosis, August 1, 2006; 12(4): 487 - 494. [Abstract] [PDF] |
||||
![]() |
K. K. Miller, B. M. K. Biller, C. Beauregard, J. G. Lipman, J. Jones, D. Schoenfeld, J. C. Sherman, B. Swearingen, J. Loeffler, and A. Klibanski Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1683 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arlt Androgen therapy in women Eur. J. Endocrinol., January 1, 2006; 154(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Rabkin, M. C. McElhiney, R. Rabkin, P. J. McGrath, and S. J. Ferrando Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) for Treatment of Nonmajor Depression in Patients With HIV/AIDS Am J Psychiatry, January 1, 2006; 163(1): 59 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
Dehydroepiandrosterone (DHEA) Obstet. Gynecol., November 1, 2005; 106(5): 1096 - 1097. [Full Text] [PDF] |
||||
![]() |
J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shafqat, L. H. Einhorn, N. Hanna, G. W. Sledge, A. Hanna, B. E. Juliar, P. Monahan, and S. Bhatia Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment{dagger} Ann. Onc., September 1, 2005; 16(9): 1545 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. van Thiel, J. A. Romijn, A. M. Pereira, N. R. Biermasz, F. Roelfsema, A. van Hemert, B. Ballieux, and J. W. A. Smit Effects of Dehydroepiandrostenedione, Superimposed on Growth Hormone Substitution, on Quality of Life and Insulin-Like Growth Factor I in Patients with Secondary Adrenal Insufficiency: A Randomized, Placebo-Controlled, Cross-Over Trial J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3295 - 3303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Boone and K. M. Shields Dietary supplements for female sexual dysfunction Am. J. Health Syst. Pharm., March 15, 2005; 62(6): 574 - 580. [Full Text] [PDF] |
||||
![]() |
K. Dhatariya, M. L. Bigelow, and K. S. Nair Effect of Dehydroepiandrosterone Replacement on Insulin Sensitivity and Lipids in Hypoadrenal Women Diabetes, March 1, 2005; 54(3): 765 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Handelsman Andro and the Prosteroids: Bolting the Stable Door J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1249 - 1251. [Full Text] [PDF] |
||||
![]() |
P. J. Schmidt, R. C. Daly, M. Bloch, M. J. Smith, M. A. Danaceau, L. Simpson St. Clair, J. H. Murphy, N. Haq, and D. R. Rubinow Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression Arch Gen Psychiatry, February 1, 2005; 62(2): 154 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valenti, L. Denti, M. Maggio, G. Ceda, S. Volpato, S. Bandinelli, G. Ceresini, A. Cappola, J. M. Guralnik, and L. Ferrucci Effect of DHEAS on Skeletal Muscle Over the Life Span: The InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): M466 - M472. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Speiser and P. C. White Congenital Adrenal Hyperplasia N. Engl. J. Med., August 21, 2003; 349(8): 776 - 788. [Full Text] [PDF] |
||||
![]() |
W. Arlt and B. Allolio DHEA Replacement in Adrenal Insufficiency J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 4001 - 4001. [Full Text] [PDF] |
||||
![]() |
K. Lovas, O. Kampe, and E. S. Husebye Authors' Response: DHEA Replacement in Adrenal Insufficiency J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 4001 - 4002. [Full Text] |
||||
![]() |
R. Baschetti Assessing chronic fatigue QJM, June 1, 2003; 96(6): 454 - 454. [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Baschetti Organic vs Cultural Explanations of Chronic Fatigue Syndrome and Fibromyalgia JAMA, March 19, 2003; 289(11): 1385 - 1385. [Full Text] [PDF] |
||||
![]() |
K. Lovas, G. Gebre-Medhin, T. S. Trovik, K. J. Fougner, S. Uhlving, B. G. Nedrebo, O. L. Myking, O. Kampe, and E. S. Husebye Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Health Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Baschetti Phantom lymphadenopathy. An association with chronic fatigue syndrome Postgrad. Med. J., March 1, 2003; 79(929): 185 - 185. [Full Text] |
||||
![]() |
M. S. Cooper and P. M. Stewart Corticosteroid Insufficiency in Acutely Ill Patients N. Engl. J. Med., February 20, 2003; 348(8): 727 - 734. [Full Text] [PDF] |
||||
![]() |
C. M. Gordon, E. Grace, S. J. Emans, H. A. Feldman, E. Goodman, K. A. Becker, C. J. Rosen, C. M. Gundberg, and M. S. LeBoff Effects of Oral Dehydroepiandrosterone on Bone Density in Young Women with Anorexia Nervosa: A Randomized Trial J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4935 - 4941. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Johannsson, P. Burman, L. Wiren, B. E. Engstrom, A. G. Nilsson, M. Ottosson, B. Jonsson, B.-A. Bengtsson, and F. A. Karlsson Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2046 - 2052. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arlt, F. Callies, I. Koehler, J. C. van Vlijmen, M. Fassnacht, C. J. Strasburger, M. J. Seibel, D. Huebler, M. Ernst, M. Oettel, et al. Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4686 - 4692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF] |
||||
![]() |
K. K. Miller Androgen Deficiency in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2395 - 2401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |